Burrill & Co. Forms Alliance With PricewaterhouseCoopers Israel Oct. 9, 2002 By Rachelle H.B. Fishman
Peptor's DiaPep277 Diabetes Product Licensed By Aventis Aug. 14, 2002 By Rachelle H.B. Fishman JERUSALEM, Israel - Peptor Ltd. said July 30 it signed a worldwide agreement with Aventis SA, granting it exclusive rights to develop and commercialize Peptor's DiaPep277 drug for the treatment of autoimmune diabetes. (BioWorld International)Read More
